Blog
Hit the Bitcoin Jackpot? Don't Let Taxes Steal Your Joy
Bitcoin (CRYPTO: BTC) provided explosive gains that have triggered more attention from the IRS. So, if you've made profits on selling Bitcoin, make sure you give the IRS a piece of the pie or you
Here's Why (and How Much) Bed Bath & Beyond's Planned Private Labels Matter
If you're reading this, you've probably also read that home goods retailer Bed Bath & Beyond (NASDAQ: BBBY) is planning to launch eight new private-label brands in the current fiscal year, six of
Even if the Market Crashes, I'm Not Selling Rocket
Rocket Companies (NYSE: RKT) has been one of the hottest, and most volatile, stocks in the financial sector this year. The nation's leading home mortgage company has gone through some wild swings
AT&T Is Getting Sued by the SEC -- Should Investors Be Worried?
Some troubling news came out last week for anyone investing in AT&T (NYSE: T). The Securities and Exchange Commission (SEC) is suing the telecom giant for misleading investors by providing nonpublic
Why Twitter, Not Square, Should Have Bought Tidal
Fintech stalwart Square (NYSE: SQ) is buying a majority stake in the streaming music service Tidal for $297 million in cash and stock. Jay-Z, who owns Tidal through his holding company, Project
Should You Sell Stitch Fix Stock After the Post-Earnings Crash?
There's no question about it. This was a rough earnings report for Stitch Fix (NASDAQ: SFIX).
In its fiscal second quarter, the personalized online styling service missed both analyst estimates and
Investors: Warren Buffett Warns This Asset Class Is a No-No
Warren Buffett's communication style may be quirky at times, but his fans and followers still hang on every word. Whether he's talking about investing fundamentals or his view of the future, Buffett
Fox Is Understating Tubi's Potential
It's been less than a year since Fox Corp. (NASDAQ: FOX) (NASDAQ: FOXA) announced it was acquiring ad-supported video platform Tubi, but there's no denying it was a smart purchase. CEO Lachlan
5 Stocks To Buy in the March Market Crash
In this video, I will talk about the five stocks worth picking up in this March. Most of them have taken a huge hit in the recent market correction. Growth stocks and especially tech stocks have
3 New Customers That Will Power Amazon Beyond the Pandemic
While COVID-19 pandemic was a terrible tragedy, Amazon.com (NASDAQ: AMZN), as perhaps the most essential business in the world during this time, had a terrific year in 2020. Sales accelerated 38%
This Could Be the Hottest Cannabis SPAC to Buy in 2021
Special purchase acquisition companies (SPACs) are some of the hottest buys of 2021. However, they also make for some ultra-risky investments, as investors don't have financial statements to look at
3 Cannabis Companies Sundial Growers Could Buy for Cash Right Now
After raising cash multiple times in February, popular cannabis company Sundial Growers (NASDAQ: SNDL) reported that its unrestricted cash totaled 610 million Canadian dollars. It then raised an
These 3 Value Stocks Are Absurdly Cheap Right Now
By all measures, the stock market looks overvalued right now, and finding cheap stocks in such a market is a difficult task. But you can still find hidden gems if you know where to look. Here are
Why Top Tech Dividend Stock Broadcom Is Still a Buy After Its Q4 Report
Share prices of chip giant Broadcom (NASDAQ: AVGO) have been hit by the recent sell-off in tech stocks. The stock price is down over 10% from all-time highs. Up some 40% from pre-pandemic levels
Are There Too Many Casinos in Las Vegas?
Las Vegas casinos are looking forward to capacity constraints being eased on March 15, which will allow them to operate at 50% capacity versus the current 35% ceiling.
Yet with more people allowed
Why CarParts.com Is Set to Beat the Market Again This Year
CarParts.com (NASDAQ: PRTS) delivered another impressive earnings report Monday night.
For its 14-week fourth-quarter, the only pure-play auto parts e-commerce company posted revenue growth of 90%
3 Overhyped Stocks I'm Avoiding in March
In the past three weeks, the NASDAQ 100 has experienced heavy sell-offs during multiple trading sessions, and the index entered correction territory on Friday after declining by more than 10% from
Is Sea Limited a Rising Star or a Falling Knife?
Sea Limited's (NYSE: SE) stock price lost about a fifth of its value over the past month as rising bond yields sparked a rotation from growth stocks to value stocks. Concerns about the Southeast
Should You Buy This Data Center SPAC IPO?
Starboard Value Acquisition Corporation (NASDAQ: SVAC) is a special purpose acquisition company (SPAC) that recently announced plans to take data center operator Cyxtera public. In this Fool Live
5 Stock Market Crash Myths That Stop You From Getting Rich
When the stock market is surging, everyone recognizes that a crash could present amazing opportunities. But when the market actually crashes, fear can take over -- we see that tens of thousands of
Is Affirm Holdings a Buy?
Affirm Holdings (NASDAQ: AFRM) is taking on credit card companies by making the payment process more transparent, flexible, and forgiving, and not charging its customers late fees.
The fintech got
3 Top Stocks to Buy During This Market Crash
Fortune has not been kind to investors over the last few weeks. In the past month alone, the NASDAQ 100 saw a 10% decline. Many investors still have vivid memories of the COVID-19-induced stock
Should You Buy Moderna in March?
Moderna (NASDAQ: MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while the S&P 500 has increased by just 30% during that time. The company's COVID-19
4 Beaten-Down Nasdaq Stocks With 57% to 78% Upside, According to Wall Street
Over the past four weeks, growth stock investors have been given a stern reminder that stocks move in both directions. In particular, the tech-heavy Nasdaq Composite has declined by a double-digit
Could Vaxart Be a Warren Buffett Stock?
Science stocks aren't exactly Warren Buffett's usual fare for investment. Aside from the high risks involved with trying to make new medicines and technologies, many companies that work at the


